In case you missed our RFS/GEN Women in Science Webinar Series, you can watch them now:


  • Katalin Karikó, PhD, Senior Vice President at BioNTech RNA Pharmaceuticals, on the “Development of the mRNA Therapeutic - Not Warp Speed!" With a career spanning four decades, the Hungarian-born biochemist’s discoveries provided scientists with the tools necessary to develop mRNA vaccines for COVID-19 (July 23).   
  • Amy Abernethy, MD, PhD, former FDA Principal Deputy Commissioner and now President of Verily’ s clinical research platforms, on “The Important Business of Clinical Trials: The Scientific, Regulatory, and Patient Implications” (August 13). 
  • Fiona E. Murray, PhD, Professor of Entrepreneurship & Associate Dean or Innovation at the MIT Sloan School of Management, on “The Generation of Commercialization of Innovation: Who is in the Room/Lab?” With a background in chemistry and applied science, Dr. Murray addresses the need to be working across sectors and across disciplines, and the compelling need to identify new and emerging opportunities in the private sector (October 1).   


  • The Life and Times of Rosalind Franklin: British biologist and author Dr. Matthew Cobb explores Franklin’s contribution to DNA structure and how they have been seen in popular culture.
  • The Empowerment of Having a Lab of One’s Own: Dr. Rita Colwell, president of the Rosalind Franklin Society, is a pioneering microbiologist and the first woman to lead the National Science Foundation. She is a Distinguished University Professor at both the University of Maryland and Johns Hopkins University’s Bloomberg School of Public Health.
  • The Great Convergence: How Biology and Engineering Unite to Reshape our World. Renowned neuroscientist Dr. Susan Hockfield, who served as president of MIT from 2004–2012, shares her views of the future that she lays out in her recent book, The Age of Living Machines: How Biology Will Build the Next Technology Revolution.
  • Conversation with special guest Nobel Prize Laureate Jennifer Doudna, PhD (University of California, Berkeley/HHMI) was recently awarded the 2020 Nobel Prize in Chemistry with Emmanuelle Charpentier, PhD,  a microbiologist at the Max Planck Institute in Berlin. Doudna has embraced her leadership role, spearheading vital discussions about the ethics of hereditary genome editing, championing the value of basic academic research, and serving as an inspirational role model for women in science.